[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].
This paper introduces some comments on the complete text of Good Pharmacovigilance Publishing Practices, which forms appendix number 2 of the Good Pharmacovigilance Practices now published by the French Drug Agency, as was Good Clinical Practices. Each good practice is printed in italic and presented in a frame; the following comments are designed to facilitate its application. The technical terms that are used in this text are presented according to the glossary in Good Pharmacovigilance Practices.
Auriche
M
M
Bertrand
P
P
Blay
N
N
Danan
G
G
Hamel
J D
JD
Imbs
J L
JL
Lagier
G
G
Micaleff
A
A
Moore
N
N
Ollagnier
M
M
Reveilleau-Richard
S
S
Soubrié
C
C
Weber
F
F
D016907:Adverse Drug Reaction Reporting Systems; D005602:France; D010506:Periodicals as Topic; D011358:Product Surveillance, Postmarketing
Les bonnes pratiques de publication de cas cliniques de pharmacovigilance: commentaires. Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentaires.